Clinical Trial: A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604545) titled 'A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema' on May 18.

Brief Summary: This study is to assess the use of Artificial intellignce (AI) to predict eye treatment changes in adult participants with diabetic macular edema (DME).

Study Start Date: May 30

Study Type: OBSERVATIONAL

Condition: Diabetic Macular Edema

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by HT Digital Content Services with permission from Health Daily Digest....